{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T09:08:40Z","timestamp":1778749720115,"version":"3.51.4"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:00:00Z","timestamp":1776211200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:00:00Z","timestamp":1776211200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Pharm"],"DOI":"10.1007\/s11096-026-02127-x","type":"journal-article","created":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T11:48:28Z","timestamp":1776253708000},"page":"1185-1186","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comment on \u201cevaluation of\u00a0high dose post-dialytic versus daily beta-lactam dosing in hemodialysis patients using Monte Carlo simulation\u201d"],"prefix":"10.1007","volume":"48","author":[{"given":"Sarah Alhassan","family":"Aljumaa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed","family":"Al Musawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rania","family":"El Lababidi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emna","family":"Abidi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Islam","family":"Ghazi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wasim S.","family":"El Nekidy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,15]]},"reference":[{"key":"2127_CR1","doi-asserted-by":"publisher","DOI":"10.1007\/s11096-025-02044-5","author":"AJ Bauman","year":"2025","unstructured":"Bauman AJ, Caiazza OG, Wan N, et al. Evaluation of high dose post-dialytic versus daily beta-lactam dosing in hemodialysis patients using Monte Carlo simulation. Int J Clin Pharm. 2025. https:\/\/doi.org\/10.1007\/s11096-025-02044-5.","journal-title":"Int J Clin Pharm"},{"issue":"2","key":"2127_CR2","doi-asserted-by":"publisher","first-page":"111","DOI":"10.5414\/CN110664","volume":"97","author":"WS El Nekidy","year":"2022","unstructured":"El Nekidy WS, Cha R, Ghazi IM. Practical considerations for vancomycin dosing in hemodialysis patients: perspectives from the nephrology stewardship pharmacist. Clin Nephrol. 2022;97(2):111\u201320. https:\/\/doi.org\/10.5414\/CN110664.","journal-title":"Clin Nephrol"},{"issue":"2","key":"2127_CR3","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1159\/000489923","volume":"8","author":"WS El Nekidy","year":"2018","unstructured":"El Nekidy WS, Soong D, Kadri A, et al. Salvage of hemodialysis catheter in staphylococcal bacteremia: case series, revisiting the literature, and the role of the pharmacist. Case Rep Nephrol Dial. 2018;8(2):121\u20139. https:\/\/doi.org\/10.1159\/000489923.","journal-title":"Case Rep Nephrol Dial"},{"issue":"4","key":"2127_CR4","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/nrmicro862","volume":"2","author":"GL Drusano","year":"2004","unstructured":"Drusano GL. Antimicrobial pharmacodynamics: critical interactions of \u201cbug and drug.\u201d Nat Rev Microbiol. 2004;2(4):289\u2013300. https:\/\/doi.org\/10.1038\/nrmicro862.","journal-title":"Nat Rev Microbiol"},{"issue":"4","key":"2127_CR5","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1093\/infdis\/158.4.831","volume":"158","author":"B Vogelman","year":"1988","unstructured":"Vogelman B, Gudmundsson S, Leggett J, et al. Correlation of antimicrobial pharmacokinetic parameters with therapeutic efficacy in an animal model. J Infect Dis. 1988;158(4):831\u201347. https:\/\/doi.org\/10.1093\/infdis\/158.4.831.","journal-title":"J Infect Dis"},{"issue":"6","key":"2127_CR6","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02446-17","volume":"62","author":"WW Nichols","year":"2018","unstructured":"Nichols WW, Newell P, Critchley IA, et al. Avibactam pharmacokinetic\/pharmacodynamic targets. Antimicrob Agents Chemother. 2018;62(6):e02446-17. https:\/\/doi.org\/10.1128\/AAC.02446-17.","journal-title":"Antimicrob Agents Chemother"},{"issue":"12","key":"2127_CR7","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1002\/phar.4629","volume":"44","author":"M Al Musawa","year":"2024","unstructured":"Al Musawa M, Bleick CR, Herbin SR, et al. Aztreonam-avibactam: the dynamic duo against multidrug-resistant gram-negative pathogens. Pharmacotherapy. 2024;44(12):927\u201338. https:\/\/doi.org\/10.1002\/phar.4629.","journal-title":"Pharmacotherapy"},{"issue":"1","key":"2127_CR8","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1128\/AAC.01269-15","volume":"60","author":"J Berkhout","year":"2015","unstructured":"Berkhout J, Melchers MJ, van Mil AC, et al. Pharmacodynamics of ceftazidime and avibactam in neutropenic mice with thigh or lung infection. Antimicrob Agents Chemother. 2015;60(1):368\u201375. https:\/\/doi.org\/10.1128\/AAC.01269-15.","journal-title":"Antimicrob Agents Chemother"},{"key":"2127_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/s40360-016-0048-y","volume":"17","author":"E Descombes","year":"2016","unstructured":"Descombes E, Martins F, Hemett OM, et al. Three-times-weekly, post-dialysis cefepime therapy in patients on maintenance hemodialysis: a retrospective study. BMC Pharmacol Toxicol. 2016;17:4. https:\/\/doi.org\/10.1186\/s40360-016-0048-y.","journal-title":"BMC Pharmacol Toxicol"},{"issue":"1","key":"2127_CR10","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s002280050721","volume":"56","author":"S Schmaldienst","year":"2000","unstructured":"Schmaldienst S, Traunm\u00fcller F, Burgmann H, et al. Multiple-dose pharmacokinetics of cefepime in long-term hemodialysis with high-flux membranes. Eur J Clin Pharmacol. 2000;56(1):61\u20134. https:\/\/doi.org\/10.1007\/s002280050721.","journal-title":"Eur J Clin Pharmacol"},{"issue":"12","key":"2127_CR11","doi-asserted-by":"publisher","first-page":"3386","DOI":"10.1093\/jac\/dkaf383","volume":"80","author":"S Smith","year":"2025","unstructured":"Smith S, Reilly CW, Stewart J, et al. Thrice-weekly post-haemodialysis ceftazidime can achieve adequate pre-dialysis concentrations and clinical cure in patients with melioidosis. J Antimicrob Chemother. 2025;80(12):3386\u201390. https:\/\/doi.org\/10.1093\/jac\/dkaf383.","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"2127_CR12","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1111\/hdi.12377","volume":"20","author":"JH Goh","year":"2016","unstructured":"Goh JH, Lee SY, Ooi ST, et al. Post-hemodialysis dosing of 1 vs. 2\u2009g of ceftazidime in anuric end-stage renal disease patients on low-flux dialysis and its pharmacodynamic implications on clinical use. Hemodial Int. 2016;20(2):253\u201360. https:\/\/doi.org\/10.1111\/hdi.12377.","journal-title":"Hemodial Int"}],"container-title":["International Journal of Clinical Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-026-02127-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11096-026-02127-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-026-02127-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T08:16:41Z","timestamp":1778746601000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11096-026-02127-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,15]]},"references-count":12,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["2127"],"URL":"https:\/\/doi.org\/10.1007\/s11096-026-02127-x","relation":{},"ISSN":["2210-7711"],"issn-type":[{"value":"2210-7711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,15]]},"assertion":[{"value":"19 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no conflicts of interest to declare","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"\u201cThe work did not require institutional Research Ethics Committee approval\u201d.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}